search
Back to results

Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression (GENI)

Primary Purpose

Psychiatric Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
study of the transmission of genetic variants
Sponsored by
Fondation FondaMental
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Psychiatric Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • For patients:
  • Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder
  • Age over 18 years
  • Subject affiliated to the social security system
  • Including patients under guardianship, curatorship,
  • Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies.
  • Having signed the consent form

For relatives :

  • Age over 18 years
  • Relative of patient included in the Fondattion FondaMental cohort
  • Including relative under guardianship, curatorship
  • Having signed the consent
  • Affiliated to social security

Exclusion Criteria:

  • For all subjects:
  • Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol
  • Persons deprived of liberty
  • Inability to understand French

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Other

    Arm Label

    Patients

    Relatives

    Arm Description

    Subject suffering from (according to DSM IV criteria) bipolar disorder unipolar depression schizophrenia autism spectrum disorder Collection of hair follicle cells

    Relatives of enrolled patients suffering from psychiatric disorder. test to detect psychiatric disorders blood or saliva sampling for genomic DNA extraction Collection of hair follicle cells

    Outcomes

    Primary Outcome Measures

    Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.
    Test for psychiatric disorders Study of the genetic variant of interest by sequencing or genotyping on genomic DNA.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 26, 2022
    Last Updated
    February 14, 2023
    Sponsor
    Fondation FondaMental
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05480826
    Brief Title
    Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
    Acronym
    GENI
    Official Title
    Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    March 15, 2023 (Anticipated)
    Primary Completion Date
    September 15, 2027 (Anticipated)
    Study Completion Date
    September 15, 2028 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Fondation FondaMental

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Genetic analyses conducted on patient with psychiatric disorders assessed at the expert centres resulted in the identific action of genetic variants associated with psychiatric disorders (Courtois, 2020). These data require further genetic and functional analyses. The first objective of this study is to investigate the disease-related inheritance of genetic variants in the families of individuals in whom these variants have been identified. The second objective is to explore the functional consequences of disease-associated genetic variants in patients cells and those of their relatives with and without these variants. The present project aims to enrich existing biocollections with DNA from blood or saliva from relatives of patients identified with genetic variants. In addition, we wish to collect hair follicules from patients with identified genetic variants of interest and their family members who wish to participate in the study. These hair samples with SNA will be used to dedifferentiate the isolated cells into induced pluripotent stem cells (IPSCs), and then to differentiate them into cells expressing the gene of interest, such as neurons or astrocytes, or into more complex systems, such as brain organoids.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Psychiatric Disorder

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    2 groups of subjects are enrolled in the study: patients with a mental disorder relatives of patients included
    Masking
    Outcomes Assessor
    Allocation
    Non-Randomized
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Patients
    Arm Type
    Other
    Arm Description
    Subject suffering from (according to DSM IV criteria) bipolar disorder unipolar depression schizophrenia autism spectrum disorder Collection of hair follicle cells
    Arm Title
    Relatives
    Arm Type
    Other
    Arm Description
    Relatives of enrolled patients suffering from psychiatric disorder. test to detect psychiatric disorders blood or saliva sampling for genomic DNA extraction Collection of hair follicle cells
    Intervention Type
    Genetic
    Intervention Name(s)
    study of the transmission of genetic variants
    Intervention Description
    the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA
    Primary Outcome Measure Information:
    Title
    Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.
    Description
    Test for psychiatric disorders Study of the genetic variant of interest by sequencing or genotyping on genomic DNA.
    Time Frame
    through study completion, an average of 5 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: For patients: Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder Age over 18 years Subject affiliated to the social security system Including patients under guardianship, curatorship, Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies. Having signed the consent form For relatives : Age over 18 years Relative of patient included in the Fondattion FondaMental cohort Including relative under guardianship, curatorship Having signed the consent Affiliated to social security Exclusion Criteria: For all subjects: Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol Persons deprived of liberty Inability to understand French
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Stephane JAMAIN, PhD
    Phone
    149813775
    Ext
    +33
    Email
    stephane.jamain@inserm.fr
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Marion Leboyer, MD PhD
    Organizational Affiliation
    Fondation FondaMental
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Stephane JAMAIN, PhD
    Organizational Affiliation
    Institut National de la Santé Et de la Recherche Médicale, France
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression

    We'll reach out to this number within 24 hrs